Výsledky vyhledávání - "Masanori Yagi"

Akademický článek

Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children

Autor: Edith Christiane Bougouma, Nirianne Marie Q. Palacpac, Alfred B. Tiono, Issa Nebie, Alphonse Ouédraogo, Sophie Houard, Masanori Yagi, Sam Aboubacar Coulibaly, Amidou Diarra, Takahiro Tougan, Amidou Z. Ouedraogo, Issiaka Soulama, Nobuko Arisue, Jean Baptiste Yaro, Flavia D’Alessio, Odile Leroy, Simon Cousens, Toshihiro Horii, Sodiomon B. Sirima

Publikováno v: Frontiers in Immunology, Vol 13 (2022)

BackgroundA blood-stage vaccine targeting the erythrocytic-stages of the malaria parasite Plasmodium falciparum could play a role to protect against clinical disease. Antibodies against the P. falciparum serine repeat antigen 5 (SE47 and SE36 domains

Externí odkaz: https://doaj.org/article/db77ababb24041078b2a6594464ac231

Zobrazit plný text záznamu

Akademický článek

Protective epitopes of the Plasmodium falciparum SERA5 malaria vaccine reside in intrinsically unstructured N-terminal repetitive sequences.

Autor: Masanori Yagi, Gilles Bang, Takahiro Tougan, Nirianne M Q Palacpac, Nobuko Arisue, Taiki Aoshi, Yoshitsugu Matsumoto, Ken J Ishii, Thomas G Egwang, Pierre Druilhe, Toshihiro Horii

Publikováno v: PLoS ONE, Vol 9, Iss 6, p e98460 (2014)

The malaria vaccine candidate antigen, SE36, is based on the N-terminal 47 kDa domain of Plasmodium falciparum serine repeat antigen 5 (SERA5). In epidemiological studies, we have previously shown the inhibitory effects of SE36 specific antibodies on

Externí odkaz: https://doaj.org/article/ca039e53734d4cca984f604e67ef3563

Zobrazit plný text záznamu

Akademický článek

Phase 1b randomized trial and follow-up study in Uganda of the blood-stage malaria vaccine candidate BK-SE36.

Publikováno v: PLoS ONE, Vol 8, Iss 5, p e64073 (2013)

BACKGROUND: Up to now a malaria vaccine remains elusive. The Plasmodium falciparum serine repeat antigen-5 formulated with aluminum hydroxyl gel (BK-SE36) is a blood-stage malaria vaccine candidate that has undergone phase 1a trial in malaria-naive J

Externí odkaz: https://doaj.org/article/d468acc1b0e04be69ab69d838b9721bb

Zobrazit plný text záznamu

Akademický článek

Serologic markers in relation to parasite exposure history help to estimate transmission dynamics of Plasmodium vivax.

Autor: Fadile Yildiz Zeyrek, Nirianne Palacpac, Fehmi Yuksel, Masanori Yagi, Kaori Honjo, Yukiko Fujita, Nobuko Arisue, Satoru Takeo, Kazuyuki Tanabe, Toshihiro Horii, Takafumi Tsuboi, Ken J Ishii, Cevayir Coban

Publikováno v: PLoS ONE, Vol 6, Iss 11, p e28126 (2011)

Plasmodium vivax infection has been gaining attention because of its re-emergence in several parts of the world. Southeastern Turkey is one of the places in which persistent focal malaria caused exclusively by P. vivax parasites occurs. Although cont

Externí odkaz: https://doaj.org/article/ff38173bf756408da2b80ed638040295

Zobrazit plný text záznamu

First-in-human randomised trial and follow-up study of Plasmodium falciparum blood-stage malaria vaccine BK-SE36 with CpG-ODN(K3)

Autor: Tomomi Yamada, Kiyoshi Okada, Takahiro Tougan, Sumiyuki Nishida, Jyotheeswara R. Edula, Yuko Oishi, Kouji Yamamoto, Toshihiro Horii, Kohhei Tetsutani, Akira Myoui, Ken Ishii, Masanori Yagi, Sachiko Ezoe, Nirianne Marie Q. Palacpac, Masaki Taira, Haruhiko Hirata, Atsushi Ogata

Publikováno v: Vaccine. 38:7246-7257

Background BK-SE36 is blood-stage malaria vaccine candidate that is undergoing clinical trials. Here, the safety and immunogenicity of BK-SE36 with a novel adjuvant, CpG-ODN(K3) (thus, BK-SE36/CpG) was assessed in a phase 1a trial in Japan. Methods A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa4b432dc82c9b6763607a5567714c30
https://doi.org/10.1016/j.vaccine.2020.09.056

Zobrazit plný text záznamu

Highly Collapsed Conformation of the Initial Folding Intermediates of β-Lactoglobulin with Non-Native α-Helix

Autor: Yuji Goto, Tsuyoshi Konuma, Masanori Yagi, Satoshi Takahashi, Kazumasa Sakurai, Tetsuro Fujisawa

Publikováno v: Journal of Molecular Biology. 427:3158-3165

In the folding of β-lactoglobulin (βLG), a predominantly β-sheet protein, a transient intermediate possessing an excess amount of non-native α-helix is formed within a few milliseconds. To characterize the early folding dynamics of βLG in terms

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2d6f84811e3e09aa41a692cd08eadb9
https://doi.org/10.1016/j.jmb.2015.07.018

Zobrazit plný text záznamu

Introduction to 'The Handbook of Microfinance'

Autor: Masanori, Yagi

Publikováno v: 21世紀社会デザイン研究 : Rikkyo journal of social design studies. 15:165-167

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=jairo_______::e485c4bd42baa4485ac6ef5ace5d6857
http://id.nii.ac.jp/1062/00014688/

Zobrazit plný text záznamu

Non-Native α-Helices in the Initial Folding Intermediate Facilitate the Ordered Assembly of the β-Barrel in β-Lactoglobulin

Autor: Satoshi Takahashi, Tsuyoshi Konuma, Yuji Goto, Chiaki Nishimura, Masanori Yagi, Kazumasa Sakurai

Publikováno v: Biochemistry. 56(36)

The roles of non-native α-helices frequently observed in the initial folding stage of β-sheet proteins have been examined for many years. We herein investigated the residue-level structures of several mutants of bovine β-lactoglobulin (βLG) in qu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8784a76be49ee5863b3cda19f90393d
https://pubmed.ncbi.nlm.nih.gov/28795569

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání